These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30381609)

  • 1. Comment to "Recurrent Glioblastoma Treated with Recombinant Poliovirus".
    Wang P; Chen GZ
    Chin Med J (Engl); 2018 Nov; 131(21):2645-2646. PubMed ID: 30381609
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.
    Brown MC; Gromeier M
    Curr Opin Virol; 2015 Aug; 13():81-5. PubMed ID: 26083317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme: the terminator.
    Holland EC
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6242-4. PubMed ID: 10841526
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
    Goetz C; Gromeier M
    Cytokine Growth Factor Rev; 2010; 21(2-3):197-203. PubMed ID: 20299272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
    Taal W; Oosterkamp HM; Walenkamp AM; Dubbink HJ; Beerepoot LV; Hanse MC; Buter J; Honkoop AH; Boerman D; de Vos FY; Dinjens WN; Enting RH; Taphoorn MJ; van den Berkmortel FW; Jansen RL; Brandsma D; Bromberg JE; van Heuvel I; Vernhout RM; van der Holt B; van den Bent MJ
    Lancet Oncol; 2014 Aug; 15(9):943-53. PubMed ID: 25035291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma.
    De Bonis P; Anile C; Pompucci A; Fiorentino A; Balducci M; Chiesa S; Maira G; Mangiola A
    Acta Neurochir (Wien); 2012 Aug; 154(8):1371-8. PubMed ID: 22718138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses.
    Sosnovtseva AO; Lipatova AV; Grinenko NF; Baklaushev VP; Chumakov PM; Chekhonin VP
    Bull Exp Biol Med; 2016 Oct; 161(6):821-825. PubMed ID: 27783287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent glioblastoma: who receives tumor specific treatment and how often?
    Steffens R; Semrau S; Lahmer G; Putz F; Lettmaier S; Eyüpoglu I; Buchfelder M; Fietkau R
    J Neurooncol; 2016 May; 128(1):85-92. PubMed ID: 26907492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
    Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence Pattern Analysis of Primary Glioblastoma.
    Rapp M; Baernreuther J; Turowski B; Steiger HJ; Sabel M; Kamp MA
    World Neurosurg; 2017 Jul; 103():733-740. PubMed ID: 28434963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses in cancer therapy - from benchwarmers to quarterbacks.
    Peruzzi P; Chiocca EA
    Nat Rev Clin Oncol; 2018 Nov; 15(11):657-658. PubMed ID: 30057404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme.
    Francesconi AB; Dupre S; Matos M; Martin D; Hughes BG; Wyld DK; Lickliter JD
    J Clin Neurosci; 2010 Aug; 17(8):970-4. PubMed ID: 20541421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bevacizumab in recurrent glioblastoma: new insights from randomized trials.
    Franceschi E; Brandes AA
    CNS Oncol; 2015; 4(3):117-9. PubMed ID: 25906382
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-Line Chemotherapy in Recurrent Glioblastoma--Still Controversial.
    Franceschi E
    Oncol Res Treat; 2015; 38(7-8):345-6. PubMed ID: 26278577
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment in patients with glioblastoma multiforme and poor performance status: is it worthwhile?
    Ampil FL; Nanda A; Willis BK; Apple S
    Radiat Med; 1998; 16(2):109-12. PubMed ID: 9650897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
    Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbalý V; Ram Z; Villano JL; Rainov N; Weinberg U; Schiff D; Kunschner L; Raizer J; Honnorat J; Sloan A; Malkin M; Landolfi JC; Payer F; Mehdorn M; Weil RJ; Pannullo SC; Westphal M; Smrcka M; Chin L; Kostron H; Hofer S; Bruce J; Cosgrove R; Paleologous N; Palti Y; Gutin PH
    Eur J Cancer; 2012 Sep; 48(14):2192-202. PubMed ID: 22608262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.